HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ning Han Selected Research

Colonic Neoplasms (Colon Cancer)

1/2022miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A.
1/2017Development of Surface-Variable Polymeric Nanoparticles for Drug Delivery to Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ning Han Research Topics

Disease

39Neoplasms (Cancer)
05/2024 - 01/2013
12Infections
02/2024 - 04/2008
10Lung Neoplasms (Lung Cancer)
05/2024 - 11/2021
8Brain Ischemia (Cerebral Ischemia)
01/2022 - 11/2011
7Diabetic Retinopathy (Retinopathy, Diabetic)
04/2023 - 07/2015
6Stroke (Strokes)
05/2024 - 06/2014
6Inflammation (Inflammations)
05/2024 - 02/2011
6Neoplasm Metastasis (Metastasis)
09/2022 - 06/2012
5Osteonecrosis (Kienbock's Disease)
01/2022 - 05/2010
5HIV Infections (HIV Infection)
02/2017 - 04/2008
4Insulin Resistance
12/2024 - 11/2022
4Bites and Stings (Sting)
05/2024 - 01/2022
4Wounds and Injuries (Trauma)
01/2024 - 03/2015
4Body Weight (Weight, Body)
05/2023 - 07/2010
4Diabetic Nephropathies (Diabetic Nephropathy)
04/2023 - 01/2019
4Carcinogenesis
01/2023 - 11/2019
4Breast Neoplasms (Breast Cancer)
04/2022 - 05/2014
4Hypertriglyceridemia
01/2022 - 08/2013
4Carcinoma (Carcinomatosis)
01/2021 - 01/2017
4Parkinson Disease (Parkinson's Disease)
01/2015 - 03/2011
3Retinoblastoma (Glioblastoma, Retinal)
04/2024 - 12/2018
3Disease Progression
12/2023 - 12/2009
3Hepatocellular Carcinoma (Hepatoma)
01/2023 - 12/2019
3Gallstones (Gallstone)
11/2022 - 07/2013
3Fatty Liver
01/2020 - 08/2013
3Ischemia
01/2017 - 03/2015
2Diabetes Mellitus
12/2024 - 01/2020
2Gestational Diabetes (Gestational Diabetes Mellitus)
12/2024 - 12/2024
2Coronary Disease (Coronary Heart Disease)
05/2024 - 03/2015
2Sepsis (Septicemia)
01/2024 - 07/2016
2Hepatitis B
12/2023 - 01/2017
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2023 - 10/2014
2Ovarian Neoplasms (Ovarian Cancer)
06/2023 - 01/2020
2Hemolysis
04/2023 - 05/2015
2Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 02/2017
2Hip Fractures (Intertrochanteric Fractures)
12/2022 - 12/2022
2Pancreatitis
11/2022 - 08/2017
2Anemia
11/2022 - 10/2013
2Brain Injuries (Brain Injury)
01/2022 - 02/2012
2Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2017
2Hypercholesterolemia
01/2022 - 03/2015

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
08/2023 - 03/2005
10Glucose (Dextrose)FDA LinkGeneric
12/2024 - 10/2014
8DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2017
7MicroRNAs (MicroRNA)IBA
01/2023 - 07/2014
6artenimol (dihydroartemisinin)IBA
05/2024 - 01/2022
6Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2014
6Antiviral Agents (Antivirals)IBA
12/2023 - 12/2009
6Retinaldehyde (Retinal)IBA
04/2023 - 01/2020
61-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2023 - 11/2021
6Peptides (Polypeptides)IBA
01/2022 - 02/2012
6Long Noncoding RNAIBA
05/2021 - 11/2018
5CytokinesIBA
05/2023 - 02/2011
5phytochlorinIBA
02/2023 - 11/2021
4HMGB1 Protein (HMG1)IBA
04/2024 - 04/2022
4SteroidsIBA
01/2022 - 05/2010
4AntioxidantsIBA
01/2022 - 03/2015
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2017 - 01/2015
4SynucleinsIBA
01/2015 - 03/2011
4ChemokinesIBA
10/2014 - 11/2011
3Triglycerides (Triacylglycerol)IBA
05/2024 - 08/2013
3Colistin (Coly-Mycin)FDA Link
02/2024 - 01/2023
3RNA (Ribonucleic Acid)IBA
12/2023 - 01/2022
3AntigensIBA
12/2023 - 01/2021
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2023 - 07/2010
3NF-kappa B (NF-kB)IBA
01/2022 - 10/2005
3Interleukin-10 (Interleukin 10)IBA
01/2022 - 08/2017
3Oxygen (Dioxygen)IBA
01/2022 - 01/2020
3NucleosidesIBA
01/2022 - 08/2013
3EnzymesIBA
01/2022 - 01/2016
3VaccinesIBA
01/2021 - 01/2020
3IMM-H004IBA
10/2017 - 03/2015
3Therapeutic UsesIBA
04/2016 - 04/2006
2CurcuminIBA
04/2024 - 12/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024 - 12/2019
2Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2023 - 10/2023
2HydrogelsIBA
12/2023 - 06/2020
2TeaIBA
12/2023 - 01/2023
2N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
11/2023 - 05/2022
2Transcription Factors (Transcription Factor)IBA
04/2023 - 02/2012
2chlorinIBA
02/2023 - 01/2022
2Tight Junction ProteinsIBA
01/2023 - 06/2015
2LipidsIBA
11/2022 - 01/2021
2Estrogen ReceptorsIBA
04/2022 - 05/2014
2Protein Subunit VaccinesIBA
01/2022 - 01/2021
2Reverse Transcriptase InhibitorsIBA
01/2022 - 08/2013
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
2InterferonsIBA
01/2022 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
11/2021 - 01/2013

Therapy/Procedure

27Therapeutics
05/2024 - 04/2006
8Immunotherapy
11/2023 - 01/2020
8Radiotherapy
01/2022 - 01/2013
8Highly Active Antiretroviral Therapy (HAART)
01/2022 - 10/2006
7Drug Therapy (Chemotherapy)
01/2022 - 06/2012
4Photochemotherapy (Photodynamic Therapy)
02/2023 - 11/2021
3Photothermal Therapy
09/2022 - 01/2021
3Art Therapy
01/2022 - 02/2017
3Lasers (Laser)
09/2021 - 01/2021
2Thrombectomy
01/2024 - 11/2023
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 10/2006